OncoImmunology, Volume 3, Issue 2 (2014)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

OncoImmunology, Volume 3, Issue 2 (2014)

See all volumes and issues
Vol 13, 2024 Vol 12, 2023 Vol 11, 2022 Vol 10, 2021 Vol 9, 2020 Vol 8, 2019 Vol 7, 2018 Vol 6, 2017 Vol 5, 2016 Vol 4, 2015 Volume 3, 2014 Vol 2, 2013 Vol 1, 2012
Download citations Download PDFs Download issue

Editorial

Editorial
Novel insights into the mechanism of action of lenalidomide
Michaela Semeraro & Lorenzo Galluzzi
Article: e28386
Published online: 01 Feb 2014
First Page PreviewforNovel insights into the mechanism of action of lenalidomide | Full Text | References | PDF (205.9 KB)
  • 1765 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
Devin B Lowe, Anamika Bose, Jennifer L Taylor, Hussein Tawbi, Yan Lin, John M Kirkwood & Walter J Storkus
Article: e27589
Published online: 27 Feb 2014
AbstractforDasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma | Full Text | References | PDF (696.1 KB) | Supplemental
  • 1603 Views
  • 32 CrossRef citations
  • 0Altmetric
Open Access
Article
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
Chang Song, Kavitha Sadashivaiah, Aki Furusawa, Eduardo Davila, Koji Tamada & Arnob Banerjee
Article: e27680
Published online: 27 Feb 2014
AbstractforEomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy | Full Text | References | PDF (1 MB)
  • 1685 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Trial Watch
Immunostimulatory monoclonal antibodies in cancer therapy
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi
Article: e27297
Published online: 01 Feb 2014
AbstractforTrial Watch | Full Text | References | PDF (408.4 KB)
  • 3086 Views
  • 90 CrossRef citations
  • 0Altmetric
Open Access

Point of View

Adverse cardiac events to monoclonal antibodies used for cancer therapy
The risk of Kounis syndrome
Nicholas G Kounis, George D Soufras, Grigorios Tsigkas & George Hahalis
Article: e27987
Published online: 14 Feb 2014
AbstractforAdverse cardiac events to monoclonal antibodies used for cancer therapy | Full Text | References | PDF (165 KB)
  • 1123 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access

Author's View

A novel pathway links telomeres to NK-cell activity
Implications for immunotherapy
Julien Cherfils-Vicini, Pasquale Zizza, Eric Gilson & Annamaria Biroccio
Article: e27358
Published online: 01 Jan 2014
AbstractforA novel pathway links telomeres to NK-cell activity | Full Text | References | PDF (285.4 KB)
  • 675 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Out of the bitter came forth sweet
Activating CD28-dependent co-stimulation via PD-1 ligands
Chen Ankri & Cyrille J Cohen
Article: e27399
Published online: 01 Jan 2014
AbstractforOut of the bitter came forth sweet | Full Text | References | PDF (245.9 KB)
  • 707 Views
  • 14 CrossRef citations
  • 0Altmetric
Open Access
Local immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer
Linda C Sandin, Thomas H Tötterman & Sara M Mangsbo
Article: e27400
Published online: 01 Jan 2014
AbstractforLocal immunotherapy based on agonistic CD40 antibodies effectively inhibits experimental bladder cancer | Full Text | References | PDF (329.1 KB)
  • 757 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Push and release
TLR9 activation plus STAT3 blockade for systemic antitumor immunity
Marcin Kortylewski & Ya-Huei Kuo
Article: e27441
Published online: 03 Jan 2014
AbstractforPush and release | Full Text | References | PDF (274.7 KB)
  • 661 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
The immune landscape of human tumors
Implications for cancer immunotherapy
Gabriela Bindea, Bernhard Mlecnik, Helen K Angell & Jérôme Galon
Article: e27456
Published online: 03 Jan 2014
AbstractforThe immune landscape of human tumors | Full Text | References | PDF (263.7 KB)
  • 3069 Views
  • 82 CrossRef citations
  • 0Altmetric
Open Access
Chemotherapy engages multiple pathways leading to IL-1β production by myeloid leukocytes
Christina Antonopoulos & George Dubyak
Article: e27499
Published online: 03 Jan 2014
AbstractforChemotherapy engages multiple pathways leading to IL-1β production by myeloid leukocytes | PDF (402.3 KB)
  • 225 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access
AMD3100 protects from UV-induced skin cancer
Scott N Byrne & Seri NE Sarchio
Article: e27562
Published online: 03 Jan 2014
AbstractforAMD3100 protects from UV-induced skin cancer | Full Text | References | PDF (592.5 KB)
  • 667 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Modulating antigen processing for cancer immunotherapy
Efstratios Stratikos
Article: e27568
Published online: 03 Jan 2014
AbstractforModulating antigen processing for cancer immunotherapy | Full Text | References | PDF (546.5 KB)
  • 935 Views
  • 23 CrossRef citations
  • 0Altmetric
Open Access
RB1-mediated cell-autonomous and host-dependent oncosuppressor mechanisms in radiation-induced osteosarcoma
Maya Kansara & David M Thomas
Article: e27569
Published online: 03 Jan 2014
AbstractforRB1-mediated cell-autonomous and host-dependent oncosuppressor mechanisms in radiation-induced osteosarcoma | Full Text | References | PDF (287.6 KB)
  • 598 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
The short and sweet of T-cell therapy
Restraining glycolysis enhances the formation of immunological memory and antitumor immune responses
Madhusudhanan Sukumar & Luca Gattinoni
Article: e27573
Published online: 03 Jan 2014
AbstractforThe short and sweet of T-cell therapy | Full Text | References | PDF (332.7 KB)
  • 949 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Immune checkpoint blockade in malignant mesothelioma
A novel therapeutic strategy against a deadly disease?
Luana Calabrò & Michele Maio
Article: e27482
Published online: 03 Jan 2014
AbstractforImmune checkpoint blockade in malignant mesothelioma | Full Text | References | PDF (311 KB)
  • 736 Views
  • 16 CrossRef citations
  • 0Altmetric
Open Access
Hypoxia and tumor-associated macrophages
A deadly alliance in support of tumor progression
Eva Van Overmeire, Damya Laoui, Jiri Keirsse & Jo A Van Ginderachter
Article: e27561
Published online: 03 Jan 2014
AbstractforHypoxia and tumor-associated macrophages | Full Text | References | PDF (432.5 KB)
  • 1152 Views
  • 26 CrossRef citations
  • 0Altmetric
Open Access
Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists
Nadia Luheshi, Gareth Davies & James Legg
Article: e27615
Published online: 06 Jan 2014
AbstractforUnderstanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists | Full Text | References | PDF (330.4 KB)
  • 892 Views
  • 10 CrossRef citations
  • 0Altmetric
Open Access
Immunosurveillance of senescent cancer cells by natural killer cells
Alexandre Iannello & David H Raulet
Article: e27616
Published online: 06 Jan 2014
AbstractforImmunosurveillance of senescent cancer cells by natural killer cells | Full Text | References | PDF (454.6 KB)
  • 1294 Views
  • 24 CrossRef citations
  • 0Altmetric
Open Access
Interleukin-30
A novel microenvironmental hallmark of prostate cancer progression
Emma Di Carlo
Article: e27618
Published online: 06 Jan 2014
AbstractforInterleukin-30 | Full Text | References | PDF (370.7 KB)
  • 629 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
Shashi Gujar, Derek Clements & Patrick W.K. Lee
Article: e27622
Published online: 06 Jan 2014
AbstractforTwo is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses | PDF (219.9 KB)
  • 250 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access
Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells
Erik Berk, Shuwen Xu & Brian J Czerniecki
Article: e27617
Published online: 06 Jan 2014
AbstractforDendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells | Full Text | References | PDF (276.9 KB)
  • 615 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Molecular regulation of macrophages in unleashing cancer-related inflammation
Feng Hong, Bill X Wu & Zihai Li
Article: e27659
Published online: 10 Jan 2014
AbstractforMolecular regulation of macrophages in unleashing cancer-related inflammation | Full Text | References | PDF (381.8 KB)
  • 643 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
Yuting Ma, Sandy Adjemian, Lorenzo Galluzzi, Laurence Zitvogel & Guido Kroemer
Article: e27663
Published online: 10 Jan 2014
AbstractforChemokines and chemokine receptors required for optimal responses to anticancer chemotherapy | Full Text | References | PDF (344.3 KB)
  • 1043 Views
  • 26 CrossRef citations
  • 0Altmetric
Open Access
Location, location, location
CD103 demarcates intraepithelial, prognostically favorable CD8+ tumor-infiltrating lymphocytes in ovarian cancer
John R Webb, Katy Milne & Brad H Nelson
Article: e27668
Published online: 10 Jan 2014
AbstractforLocation, location, location | Full Text | References | PDF (347.6 KB)
  • 1042 Views
  • 39 CrossRef citations
  • 0Altmetric
Open Access
Toll-like receptor genetic variants and colorectal cancer
Alexander NR Weber & Asta Försti
Article: e27763
Published online: 10 Jan 2014
AbstractforToll-like receptor genetic variants and colorectal cancer | Full Text | References | PDF (348.9 KB)
  • 585 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access
Bone marrow-derived CD13+ cells sustain tumor progression
A potential non-malignant target for anticancer therapy
Eleonora Dondossola, Angelo Corti, Richard L Sidman, Wadih Arap & Renata Pasqualini
Article: e27716
Published online: 16 Jan 2014
AbstractforBone marrow-derived CD13+ cells sustain tumor progression | Full Text | References | PDF (279.4 KB)
  • 790 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Trick and treat
Ambushing recurrent tumors before they get out of the door
Nicolas Boisgerault & Richard G Vile
Article: e27811
Published online: 16 Jan 2014
AbstractforTrick and treat | Full Text | References | PDF (313.2 KB)
  • 438 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Combinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer
Aizea Morales-Kastresana, Sara Labiano, Ines Gütgemann & Ignacio Melero
Article: e27812
Published online: 16 Jan 2014
AbstractforCombinations of immunostimulatory antibodies with synergistic effects against spontaneous cancer | Full Text | References | PDF (199.9 KB)
  • 801 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Neonatal Fc receptors for IgG drive CD8+ T cell-mediated anti-cancer immunosurveillance at tolerogenic mucosal sites
Kristi Baker, Timo Rath, Michal Pyzik & Richard S Blumberg
Article: e27844
Published online: 14 Feb 2014
AbstractforNeonatal Fc receptors for IgG drive CD8+ T cell-mediated anti-cancer immunosurveillance at tolerogenic mucosal sites | Full Text | References | PDF (851.2 KB)
  • 771 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism
Iñaki Eguren-Santamaría et al.
Article | Published online: 9 Jul 2024
Open Access
SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion
Zheng Chen et al.
Article | Published online: 9 Jul 2024
Open Access
Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytes
Gwenann Cadiou et al.
Article | Published online: 8 Jul 2024
Open Access
Characterization of double-negative T cells in colorectal cancers and their corresponding lymph nodes
Kazumi Okamura et al.
Article | Published online: 4 Jul 2024
Open Access
View all latest articles